Thimerosal

• USES: • For the temporary relief of symptoms including: • fever • headache • muscle pain • rash • cough • lethargy • aching back These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.ICD-10: R05.9, R51.9

DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing.

Recent PubMed references pinned to Thimerosal as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Thimerosal Inhibits Tumor Malignant Progression through Direct Action and Enhancing the Efficacy of PD-1-Based Immunotherapy.
  Oncology research · 2026 · Wang P, Chen YH, Zhan ZT, et al.
  PMID 41613797DOI 10.32604/or.2025.071902
• Retention behavior of Hg(2+), MeHg(+), thimerosal and phenylmercuric acetate on a C(18) RP-HPLC column.
  Journal of chromatography. A · 2025 · Le MVK, Pourzadi N, Gailer J, et al.
  PMID 39608236DOI 10.1016/j.chroma.2024.465546
• Adverse effects of thimerosal on the early life stages of zebrafish.
  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP · 2025 · Li L, Dong K, Li L, et al.
  PMID 39307513DOI 10.1016/j.cbpc.2024.110046
• Exposure to thimerosal induces behavioral abnormality in the early life stages of zebrafish via altering amino acid homeostasis.
  Journal of hazardous materials · 2024 · Qiu X, Zhang Y, Gao J, et al.
  PMID 39154483DOI 10.1016/j.jhazmat.2024.135548
• Sex-specific impacts of thimerosal on the behaviors and brain monoaminergic systems in zebrafish (Danio rerio).
  Aquatic toxicology (Amsterdam, Netherlands) · 2024 · Qiu X, Su Z, Gao J, et al.
  PMID 38615580DOI 10.1016/j.aquatox.2024.106921
• Sperm induce a secondary increase in ATP levels in mouse eggs that is independent of Ca2+ oscillations.
  The Biochemical journal · 2023 · Ikie-Eshalomi C, Aliyev E, Hoehn S, et al.
  PMID 38014506DOI 10.1042/BCJ20230065
• Analysis of patch testing results in patients with contact dermatitis in Istanbul, Turkey, from 2012 to 2022.
  Journal of cosmetic dermatology · 2023 · Ünal A
  PMID 37103790DOI 10.1111/jocd.15791
• Comparative characteristics between calyculin A-induced and thimerosal-induced hyperactivation of cryopreserved bovine spermatozoa.
  The Journal of reproduction and development · 2023 · Miyamoto N, Ohya A, Duritahala, et al.
  PMID 37081666DOI 10.1262/jrd.2023-007

The 10 most recently updated of 48 ClinicalTrials.gov registrations naming Thimerosal as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia
  Active not recruiting · Phase 3 · Interventional · 8,686 enrolled · Universidad Nacional de Colombia
  NCT06223919updated 2025-09-04
• Efficacy of the Vacucis Candida® Autovaccine
  Not yet recruiting · Interventional · 46 enrolled · University of Santiago de Compostela
  NCT05289375updated 2024-10-17
• Safety and Immunogenicity Study of Thiomersal-free Hepatitis E Vaccine in People Ages 16 Years and Above
  Completed · Phase 4 · Interventional · 612 enrolled · Xiamen Innovax Biotech Co., Ltd
  NCT06564116updated 2024-08-21
• Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Elderly
  Unknown · Phase 3 · Interventional · 816 enrolled · Mahidol University
  NCT04548518updated 2022-08-25
• Immunological Characteristics of a Population at Risk of Cholera After Oral Cholera Vaccine (CHOVAXIM)
  Completed · Interventional · 225 enrolled · Centre for Infectious Disease Research in Zambia
  NCT04423159updated 2022-07-20
• Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine
  Completed · Phase 3 · Interventional · 301 enrolled · Sanofi Pasteur, a Sanofi Company
  NCT03391193updated 2022-04-25
• A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19
  Completed · Phase 2 · Interventional · 28 enrolled · Beech Tree Labs, Inc.
  NCT04522830updated 2021-04-13
• Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers
  Completed · Phase 1 · Phase 2 · Interventional · 304 enrolled · PATH
  NCT02097472updated 2019-10-10
• Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants
  Completed · Phase 1 · Phase 2 · Interventional · 346 enrolled · PATH
  NCT02308540updated 2019-08-02
• A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines
  Completed · Observational · 414 enrolled · GlaxoSmithKline
  NCT02415842updated 2019-07-23

Frequently asked questions

What is Thimerosal used for?

According to FDA labeling, Thimerosal carries indications including: USES: • For the temporary relief of symptoms including: • fever • headache • muscle pain • rash • cough • lethargy • aching back These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.

What class of drug is Thimerosal?

Thimerosal is classified as Mercurial products, Standardized Chemical Allergen, Cell-mediated Immunity, Increased Histamine Release.